NorthStar Medical Radioisotopes Receives Electron Beam Accelerator for First-of-its-Kind, Commercial-scale U.S. Production of Important Therapeutic Radioisotope Actinium-225 (Ac-225)

NorthStar is poised to be the first commercial-scale producer of rare radioisotope, in chronic short supply, for use in clinical studies and patient healthcare to treat many types of cancer 

Related Keywords

Wisconsin ,United States ,Beloit ,Stephen Merrick ,Northstar Medical Radioisotopes ,He High Energy ,Euronext ,High Energy ,Chief Executive Officer ,Northstar Medical ,Drug Master File ,